These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38583128)

  • 1. Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review.
    van Gendt J; Emaus R; Visschedijk MC; Touw DJ; Bouwknegt DG; de Leeuw K; Prins JR; Malik P; Mian P
    Clin Pharmacokinet; 2024 May; 63(5):589-622. PubMed ID: 38583128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
    Mahadevan U; Wolf DC; Dubinsky M; Cortot A; Lee SD; Siegel CA; Ullman T; Glover S; Valentine JF; Rubin DT; Miller J; Abreu MT
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):286-92; quiz e24. PubMed ID: 23200982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs.
    Groen F; Prins JR; Hooge MNL; Winter HLJ; Kosterink JGW; Touw DJ; Mian P
    Clin Pharmacokinet; 2023 Mar; 62(3):399-434. PubMed ID: 36940039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I-Penicillins.
    Hesse MR; Prins JR; Hooge MNL; Winter HLJ; Kosterink JGW; Touw DJ; Mian P
    Clin Pharmacokinet; 2023 Feb; 62(2):221-247. PubMed ID: 36662480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
    Ternant D; Bejan-Angoulvant T; Passot C; Mulleman D; Paintaud G
    Clin Pharmacokinet; 2015 Nov; 54(11):1107-23. PubMed ID: 26123705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A guide to rational dosing of monoclonal antibodies.
    Bai S; Jorga K; Xin Y; Jin D; Zheng Y; Damico-Beyer LA; Gupta M; Tang M; Allison DE; Lu D; Zhang Y; Joshi A; Dresser MJ
    Clin Pharmacokinet; 2012 Feb; 51(2):119-35. PubMed ID: 22257150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marketed therapeutic antibodies compendium.
    Reichert JM
    MAbs; 2012; 4(3):413-5. PubMed ID: 22531442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review.
    Wiersma TK; Visschedijk MC; de Boer NK; Lub-de Hooge MN; Prins JR; Touw DJ; Mian P
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of biologic therapy in biologic-naïve patients with Crohn disease: a systematic review and network meta-analysis.
    Singh S; Garg SK; Pardi DS; Wang Z; Murad MH; Loftus EV
    Mayo Clin Proc; 2014 Dec; 89(12):1621-35. PubMed ID: 25441399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.
    Buurman DJ; Blokzijl T; Festen EAM; Pham BT; Faber KN; Brouwer E; Dijkstra G
    PLoS One; 2018; 13(12):e0208922. PubMed ID: 30533022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.
    Gisbert JP; Marín AC; McNicholl AG; Chaparro M
    Aliment Pharmacol Ther; 2015 Apr; 41(7):613-23. PubMed ID: 25652884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.
    Mahadevan U; Cucchiara S; Hyams JS; Steinwurz F; Nuti F; Travis SP; Sandborn WJ; Colombel JF
    Am J Gastroenterol; 2011 Feb; 106(2):214-23; quiz 224. PubMed ID: 21157441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease.
    Grišić AM; Dorn-Rasmussen M; Ungar B; Brynskov J; Ilvemark JFKF; Bolstad N; Warren DJ; Ainsworth MA; Huisinga W; Ben-Horin S; Kloft C; Steenholdt C
    United European Gastroenterol J; 2021 Feb; 9(1):91-101. PubMed ID: 33079627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics interactions of monoclonal antibodies.
    Ferri N; Bellosta S; Baldessin L; Boccia D; Racagni G; Corsini A
    Pharmacol Res; 2016 Sep; 111():592-599. PubMed ID: 27438459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology.
    Bajaj G; Suryawanshi S; Roy A; Gupta M
    Br J Clin Pharmacol; 2019 Sep; 85(9):2045-2058. PubMed ID: 31140642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis.
    Whaley KG; Xiong Y; Karns R; Hyams JS; Kugathasan S; Boyle BM; Walters TD; Kelsen J; LeLeiko N; Shapiro J; Waddell A; Fox S; Bezold R; Bruns S; Widing R; Haberman Y; Collins MH; Mizuno T; Minar P; D'Haens GR; Denson LA; Vinks AA; Rosen MJ
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1338-1347. PubMed ID: 36031093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic models of anti-PD-1 mAbs in patients with multiple tumor types: A systematic review.
    Shang J; Huang L; Huang J; Ren X; Liu Y; Feng Y
    Front Immunol; 2022; 13():871372. PubMed ID: 35983041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.